Evidence map›Paper›PMID 22956488›Full record

ArticleImmunologic research2013

Activation of Aicda gene transcription by Pax5 in plasmacytoma cells.

Carissa Dege, James Hagman

Open access · greenAbstract read
In one paragraph

Article in Immunologic research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Cancer prevention research (Philadelphia, Pa.) · 2019
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Carissa DegeIntegrated Department of Immunology, National Jewish Health, Denver, CO 80206, USA.
James Hagman
University of Colorado Denver · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Function and Regulation of Early B Cell Factor (EBF)R01AI054661 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R. · 2004 to 2011
$2.9M
Regulation of B Cell Development and Function by Zfp521R01AI098417 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R. · 2012 to 2016
$2.0M
Regulation of B Cell Identity and Lineage ProgressionR01AI081878 · NIAID · NATIONAL JEWISH HEALTH · PI HAGMAN, JAMES R. · 2010 to 2014
$1.9M
NCI NIH HHS P30 CA046934NIAID NIH HHS AI081878NIAID NIH HHS R01 AI054661NIAID NIH HHS R01 AI081878NIAID NIH HHS R01 AI098417
6 · The paper itself

Abstract

Activation-induced deaminase (AID) is an enzyme responsible for somatic hypermutation and immunoglobulin heavy chain class switch recombination. Because AID causes double-stranded breaks in DNA, its expression is highly regulated and is normally restricted to germinal-center B cells. Dysregulated AID expression can lead to cancer as a result of AID-mediated chromosomal translocations. Many transcription factors including paired box protein 5 (Pax5) have been implicated in regulating the expression of Aicda, the gene encoding AID. In this study, we demonstrate that exogenous expression of Pax5 in a murine plasmacytoma cell line, 558LμM, leads to robust activation of endogenous Aicda transcription. Pax5 is known to initiate transcription through both its N-terminal-paired DNA-binding domain and its C-terminal-activation domain. Through mutational analysis, we demonstrate that Pax5 regulates Aicda transcription through its C-terminal-activation domain. Together, our work describes a novel system that will be useful for determining how Pax5 regulates Aicda transcription.

Indexed as

AICDA (Activation-Induced Cytidine Deaminase)AnimalsCell LineCytidine DeaminaseMicePAX5 Transcription FactorPlasmacytomaTranscription, GeneticAICDA (Activation-Induced Cytidine Deaminase)Cytidine DeaminasePAX5 Transcription Factor

Identifiers

PMID22956488
PMCPMC3844280
OpenAlexW2112758540

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.